Results of interdisciplinary oncological care;Ergebnisse der interdisziplinären onkologischen Versorgung

Onkologe

Volumn 15, Issue 11, 2009, Pages 1120-1133

  Holzel D ^a   Schubert Fritschle, G ^a   Engel, J ^a,b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cancer; Cancer registry; Course of disease; Evaluation; Outcome

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; TRASTUZUMAB;

ADJUVANT THERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER REGISTRY; CANCER THERAPY; CLINICAL COMPETENCE; COLORECTAL CARCINOMA; CRITICAL THINKING; EXPERIENCE; GERMANY; HEALTH CARE SYSTEM; HUMAN; KNOWLEDGE; MEDICAL CARE; MEDICAL EXPERT; ONCOLOGY; OUTCOME ASSESSMENT; PHYSICIAN; PRIMARY PREVENTION; REVIEW; TESTIS TUMOR;

EID: 75549088709     PISSN: 09478965     EISSN: 14330415     Source Type: Journal    
DOI: 10.1007/s00761-009-1674-4     Document Type: Review

References (30)

1. Bergstrom A, Pisani P, Tenet V et al (2001) Overweight as an avoidable cause of cancer in Europe. Int J Cancer 91:421430
2. Berrino F Brief vom 3. Juni 2002
3. Berrino F, De Angelis R, Sant M et al (2007) Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: Results of the EUROCARE-4 study. Lancet Oncol 8:773783
4. Birkmeyer Jd, Siewers Ae, Finlayson Ev et al (2002) Hospital volume and surgical mortality in the United States. N Engl J Med 346:11281137
5. Carrick S, Parker S, Thornton Ce et al (2009) Single agent versus combination chemotherapy for metastatic breast cancer. Cochrane Database Syst Rev:CD003372
6. Chlebowski Rt, Kuller Lh, Prentice Rl et al (2009) Breast cancer after use of estrogen plus progestin in postmenopausal women. N Engl J Med 360:573587
7. Curado M, Edwards B, Shin H et al (2007) Cancer Incidence in Five Continents, Vol. IX. IARC Scientific Publication No.160
8. Dawood S, Broglio K, Gonzalez-Angulo Am et al (2008) Trends in survival over the past two decades among white and black patients with newly diagnosed stage IV breast cancer. J Clin Oncol 26:48914898
9. Engel J, Eckel R, Kerr J et al (2003) The process of metastasisation for breast cancer. Eur J Cancer 39:17941806
10. Engel J, Kerr J, Eckel R et al (2005) Quality of treatment in routine care in a population sample of rectal cancer patients. Acta Oncol 44:6574
11. Engel J, Kerr J, Schlesinger-Raab A et al (2004) Quality of life following breast-conserving therapy or mastectomy: Results of a 5-year prospective study. Breast J 10:223231
12. Gatta G, Capocaccia R, Sant M et al (2000) Understanding variations in survival for colorectal cancer in Europe: A EUROCARE high resolution study. Gut 47:533538
13. Hofstädter F, Hölzel D (2008) Was leisten Tumorregister für die Qualitätssicherung in der Onkologie? Onkologe 14:12201233
14. Hölzel D (1997) Das Internet: Eine Chance für die Medizin? Onkologe 3:129134
15. International Agency for Research on Cancer Globocan 2002 http://www-dep.iarc.fr
16. Jeffery M, Hickey Be, Hider Pn (2007) Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev:CD002200
17. Jemal A, Siegel R, Ward E et al (2008) Cancer statistics, 2008. CA Cancer J Clin 58:7196
18. Lin Nu, Winer Ep (2007) Brain metastases: The HER2 paradigm. Clin Cancer Res 13:16481655
19. Monninkhof Em, Elias Sg, Vlems Fa et al (2007) Physical activity and breast cancer: A systematic review. Epidemiology 18:137157
20. Rehm J, Mathers C, Popova S et al (2009) Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet 373:22232233
21. Robert Koch Institut Gesundheitsberichterstattung und Epidemiologie- Dachdokumentation Krebs: http://www.rki.de
22. Rojas Mp, Telaro E, Russo A et al (2005) Follow-up strategies for women treated for early breast cancer. Cochrane Database Syst Rev:CD001768
23. Sant M, Allemani C, Capocaccia R et al (2003) Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer 106:416422
24. Sauer R, Becker H, Hohenberger W et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:17311740
25. Slamon Dj, Leyland-Jones B, Shak S et al (2001) Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 344:783792
26. Surveillance Epidemiology and End Results (Seer) Cancer Statistics: http://seer.cancer.gov/
27. Tumorregister München http://www.tumorregister-muenchen.de
28. Wang J, Hassett Jm, Dayton Mt et al (2008) Lymph node ratio: Role in the staging of node-positive colon cancer. Ann Surg Oncol 15:16001608
29. Wolin Ky, Yan Y, Colditz Ga et al (2009) Physical activity and colon cancer prevention: A meta-analysis. Br J Cancer 100:611616
30. Wong Sl, Ji H, Hollenbeck Bk et al (2007) Hospital lymph node examination rates and survival after resection for colon cancer. JAMA 298:21492154